Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABN1581 Anti-CLCA4 Antibody, clone 1C5.1

MABN1581
100 μg  
Purchase on Sigma-Aldrich

Különleges ajánlatok

Áttekintés

Replacement Information

Különleges ajánlatok

Kulcsspecifikációk táblázata

Species ReactivityKey ApplicationsHostFormatAntibody Type
HWB, IH(P)MPurifiedMonoclonal Antibody
Description
Catalogue NumberMABN1581
DescriptionAnti-CLCA4 Antibody, clone 1C5.1
Alternate Names
  • Calcium-activated chloride channel regulator 4
  • CaCC-2
  • Calcium-activated chloride channel family member 4
  • Calcium-activated chloride channel protein 2
  • hCaCC-2
  • hCLCA4
  • Calcium-activated chloride channel regulator 4, 110 kDa form
Background InformationCalcium-activated chloride channel regulator 4 (UniProt Q14CN2; also known as CaCC-2, Calcium-activated chloride channel family member 4, Calcium-activated chloride channel protein 2, hCaCC-2, hCLCA4) is encoded by the CLCA4 (also known as CaCC2) gene (ORF UNQ562/PRO1124; Gene ID 22802) in human. CLCA4 (CaCC2) belongs to the calcium-activated chloride channel regulator (previously known as chloride channel calcium activated or CLCA) family of self-cleaving, secreted metalloproteases that activate calcium-dependent chloride currents (ICaCC) in mammalian cells. Originally thought to be calcium-activated chloride channels (CaCCs) themselves, CLCA proteins were later identified as secreted CaCCs modulators. Among the four CLCA genes identified in human genome, only three (CLCA1/CACC1, CLCA2/CACC3, CLCA4/CACC2) encode functional Cl channel accessory proteins. CLCA4 is predominantly expressed in colon along with CLCA1, and both are reportedly downregulated in colorectal cancer cells. CLCA4 is also reported to be downregulated in breast cancer cells and exogenous CLCA4 overexpression inhibits breast cancer cell proliferation, while CLCA4 knockdown induces epithelial-to-mesenchymal transition (EMT) in mammary epithelial cells. CLCA4 is produced with a signal peptide sequence (a.a. 1-21) that is removed posttranslationally. Similar to other CLCA members, CLCA4 is further processed proteolytically by its metalloprotease domain (a.a. 45-119) to yield a 110 kDa soluble form and a 30 kDa membrane-bound form. The soluble fragment of all CLCA members also contains a von Willebrand factor type A (VWA) domain that in the case of CLCA2 is shown to engage interaction with beta4-integrin.
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal IgG2aκ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-CLCA4 Antibody, clone 1C5.1 is an antibody against CLCA4 for use in Western Blotting, Immunohistochemistry (Paraffin).
Key Applications
  • Western Blotting
  • Immunohistochemistry (Paraffin)
Application NotesImmunohistochemistry Analysis: A 1:50 dilution from a representative lot detected CLCA4 in human cerebellum, colon, kidney and testis tissue sections.
Biological Information
ImmunogenGST-tagged recombinant human CLCA4 metalloprotease domain fragment (~40 kDa).
EpitopeMetalloprotease domain.
Clone1C5.1
ConcentrationPlease refer to lot specific datasheet.
HostMouse
SpecificityClone 1C5.1 recognizes a metalloprotease domain epitope that is not present in the 30 kDa membrane-bound form or the spliced isoforms 2 reported by UniProt (Q14CN2).
IsotypeIgG2aκ
Species Reactivity
  • Human
Species Reactivity NoteHuman.
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • CLCA4
  • CaCC2
  • UNQ562/PRO1124
Purification MethodProtein G Purified
UniProt Number
Molecular Weight101.3 kDa (pro-form) and 98.89 kDa (mature form) calculated. Uncharacterized band(s) may appear in some lysates.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting of human CLCA4 GST fusion protein.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected recombinant human CLCA4 metalloprotease domain fragment GST fusion protein.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 μg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalógusszám GTIN
MABN1581 04055977350456